UA107552U - METHOD OF MODELING OF DISORDER OF FUNCTION OF SEXUAL BODIES ON CHRONIC TOXIC HEPATITIS - Google Patents
METHOD OF MODELING OF DISORDER OF FUNCTION OF SEXUAL BODIES ON CHRONIC TOXIC HEPATITISInfo
- Publication number
- UA107552U UA107552U UAU201512899U UAU201512899U UA107552U UA 107552 U UA107552 U UA 107552U UA U201512899 U UAU201512899 U UA U201512899U UA U201512899 U UAU201512899 U UA U201512899U UA 107552 U UA107552 U UA 107552U
- Authority
- UA
- Ukraine
- Prior art keywords
- modeling
- toxic hepatitis
- disorder
- function
- chronic toxic
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Спосіб моделювання порушення функції статевих органів на фоні токсичного гепатиту, що включає введення тетрахлорметану піддослідним білим щурам внутрішньошлунково, через день, у вигляді 50 % олійного розчину в дозі 2 г/кг маси тіла тварини, виведення тварин з експерименту в умовах знечулення тіопентал-натрієм з наступним забором крові для біохімічних, імунологічних, гормональних досліджень. Проводять видалення гіпофіза, яєчників, матки та печінки для морфологічного дослідження, що дозволяє відтворити експериментально і вивчити особливості порушення функції статевих органів на тлі хронічного токсичного гепатиту.Method for modeling genital dysfunction against toxic hepatitis, including administration of tetrachloromethane to experimental white rats intragastrically, every other day, in the form of 50% oil solution at a dose of 2 g / kg of body weight of the animal, exclusion of animals from thiopenthal following blood sampling for biochemical, immunological, hormonal studies. The pituitary, ovaries, uterus and liver are removed for morphological examination, which allows to reproduce experimentally and to study the peculiarities of dysfunction of the genitals on the background of chronic toxic hepatitis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201512899U UA107552U (en) | 2015-12-28 | 2015-12-28 | METHOD OF MODELING OF DISORDER OF FUNCTION OF SEXUAL BODIES ON CHRONIC TOXIC HEPATITIS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201512899U UA107552U (en) | 2015-12-28 | 2015-12-28 | METHOD OF MODELING OF DISORDER OF FUNCTION OF SEXUAL BODIES ON CHRONIC TOXIC HEPATITIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA107552U true UA107552U (en) | 2016-06-10 |
Family
ID=56561735
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201512899U UA107552U (en) | 2015-12-28 | 2015-12-28 | METHOD OF MODELING OF DISORDER OF FUNCTION OF SEXUAL BODIES ON CHRONIC TOXIC HEPATITIS |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA107552U (en) |
-
2015
- 2015-12-28 UA UAU201512899U patent/UA107552U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201891509A1 (en) | METHODS OF TREATING CANCER | |
| EA201491161A1 (en) | FLUORINATED ESTROGEN RECEPTOR MODULATORS AND THEIR APPLICATION | |
| CL2018003284A1 (en) | Methods of treatment of autoimmune diseases using allogeneic T lymphocytes. | |
| BR112017014361A2 (en) | methods for perfecting cell therapy | |
| PE20161034A1 (en) | COMPOSITIONS AND METHODS TO REDUCE SERIOUS CARDIOVASCULAR ADVERSE EVENTS | |
| CL2017000664A1 (en) | Injectable microparticles for hyper-localized release of therapeutic agents | |
| MA38460B1 (en) | Purine derivatives as cb2 receptor agonists | |
| EA201692469A1 (en) | DERIVATIVE 2-ACYLAMINOTHIAOSOL OR ITS SALT | |
| EA201591391A1 (en) | DERIVATIVE 2-ACYLAMINOTHIAOSOL OR ITS SALT | |
| CL2019003743A1 (en) | Gastro-resistant controlled release and oral dosage forms. | |
| AR110471A1 (en) | PHARMACEUTICAL HYDROCORTISONE SOLUTION FOR INJECTION DEVICE, PREPARATION PROCEDURE AND KIT | |
| RU2016141462A (en) | NEUROPROTECTIVE AGENTS AND THEIR APPLICATION | |
| UA107552U (en) | METHOD OF MODELING OF DISORDER OF FUNCTION OF SEXUAL BODIES ON CHRONIC TOXIC HEPATITIS | |
| AR089114A1 (en) | PREVENTION OF ADVERSE EFFECTS CAUSED BY BISPECIFIC ANTIBODIES EpCAMxCD3 | |
| CL2015001539A1 (en) | Method to produce autologous tolerogenic dendritic cells (toldcs) with specific antigens; toldcs obtained by said method; and its use in the preparation of a drug useful for the treatment of systemic lupus erythematosus (les) | |
| EA201692514A1 (en) | PHARMACEUTICAL COMPOSITIONS ON THE BASIS OF SOFOSBUVIR AND RIBAVIRIN WITH MODIFIED FREEDOM | |
| MA40844A (en) | LONG-ACTING PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C | |
| MA42419A (en) | METHOD OF TREATMENT OF HEPATIC ENCEPHALOPATHY | |
| BR112016026422A2 (en) | pharmaceutical solution comprising dopamine for use in the treatment of parkinson's disease | |
| EA201692515A1 (en) | NEW PHARMACEUTICAL COMPOSITION ON THE BASIS OF SOFOSBUVIRA AND RIBAVIRIN | |
| UA102518U (en) | A METHOD OF SIMULATION OF THE DICLOFENAC EFFECTS OF SODIUM ON RED BONE BRAIN RATES IN THE EXPERIMENT | |
| UA102519U (en) | METHOD OF MODELING THE DIFFLENAC SODIUM EFFECTS ON RED BONE BRAIN INDICATORS IN THE EXPERIMENT | |
| RU2016117845A (en) | CHEMICAL GASTRITIS MODELING METHOD | |
| RU2014117221A (en) | METHOD FOR MODELING CHRONIC TOXIC ARTERIAL HYPERTENSION AND CARDIOPATHY | |
| BR112020002308A2 (en) | methods for hcv treatment |